Hospital Juan Canalejo Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2011
NCT01299922
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

phenytoin (mesantoin) (1 trial)

Drugs in Phase 3 Trials (3)

cyclosporine (sandimmune) (1 trial)

mycophenolate (CellCept) (1 trial)

prednisone (meticorten) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lupus Nephritis (Phase 3)

Meningitis (Phase 4)

Meningitis, Pneumococcal (Phase 4)

Nephritis (Phase 3)

Seizures (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4